Clinical trial
Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart…
NCT00462774 · German Heart Institute, Other · Completed
Key facts
| NCT number | NCT00462774 |
|---|---|
| Title | Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure |
| Official title | Evaluierung Eines Therapiemodells Der Autologen Knochenmark-Transplantation Bei Herzerkrankungen Mit Besonderem Schwerpunkt Der Prüfung Verschiedener Progenitorzellen |
| Acronym | Cardio133 |
| Lead sponsor | German Heart Institute, Other |
| Collaborators | Miltenyi Biomedicine GmbH Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease With Need for Bypass Surgery, Myocardial Ischemia, Angina Pectoris, Congestive Heart Failure, Previous Myocardial Infarction |
| Intervention type | Procedure |
| Interventions | Intramyocardial injection of autologous CD133+ marrow cells |
| Enrollment | 60 |
| Start date | Apr 1, 2007 |
| Primary completion | Jun 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | Apr 19, 2007 |
| Last update posted | Jan 16, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: